These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 2846890

  • 1. Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome.
    Benson JD, Huang ES.
    J Virol; 1988 Dec; 62(12):4797-800. PubMed ID: 2846890
    [Abstract] [Full Text] [Related]

  • 2. Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: a new strategy for the treatment of human cytomegalovirus infection.
    Huang ES, Benson JD, Huong SM, Wilson B, van der Horst C.
    Antiviral Res; 1992 Jan; 17(1):17-32. PubMed ID: 1310581
    [Abstract] [Full Text] [Related]

  • 3. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG.
    Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551
    [Abstract] [Full Text] [Related]

  • 4. Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
    Woynarowski JM, Sigmund RD, Beerman TA.
    Biochim Biophys Acta; 1988 May 06; 950(1):21-9. PubMed ID: 2833925
    [Abstract] [Full Text] [Related]

  • 5. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
    Del Bino G, Skierski JS, Darzynkiewicz Z.
    Exp Cell Res; 1991 Aug 06; 195(2):485-91. PubMed ID: 1649059
    [Abstract] [Full Text] [Related]

  • 6. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S, Riou G.
    Biochem Pharmacol; 1994 Aug 30; 48(5):975-84. PubMed ID: 8093110
    [Abstract] [Full Text] [Related]

  • 7. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
    Estey EH, Silberman L, Beran M, Andersson BS, Zwelling LA.
    Biochem Biophys Res Commun; 1987 Apr 29; 144(2):787-93. PubMed ID: 3034264
    [Abstract] [Full Text] [Related]

  • 8. DNA topoisomerase II from mammalian mitochondria is inhibited by the antitumor drugs, m-AMSA and VM-26.
    Lin JH, Castora FJ.
    Biochem Biophys Res Commun; 1991 Apr 30; 176(2):690-7. PubMed ID: 1851000
    [Abstract] [Full Text] [Related]

  • 9. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.
    Del Bino G, Darzynkiewicz Z.
    Cancer Res; 1991 Feb 15; 51(4):1165-9. PubMed ID: 1997159
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
    Nelson EM, Tewey KM, Liu LF.
    Proc Natl Acad Sci U S A; 1984 Mar 15; 81(5):1361-5. PubMed ID: 6324188
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.
    Kaufmann WK, Boyer JC, Estabrooks LL, Wilson SJ.
    Mol Cell Biol; 1991 Jul 15; 11(7):3711-8. PubMed ID: 1646393
    [Abstract] [Full Text] [Related]

  • 12. Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo.
    Richter A, Strausfeld U, Knippers R.
    Nucleic Acids Res; 1987 Apr 24; 15(8):3455-68. PubMed ID: 3033604
    [Abstract] [Full Text] [Related]

  • 13. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
    Bakic M, Chan D, Andersson BS, Beran M, Silberman L, Estey E, Ricketts L, Zwelling LA.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4067-77. PubMed ID: 2825713
    [Abstract] [Full Text] [Related]

  • 14. Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions.
    Ketron AC, Denny WA, Graves DE, Osheroff N.
    Biochemistry; 2012 Feb 28; 51(8):1730-9. PubMed ID: 22304499
    [Abstract] [Full Text] [Related]

  • 15. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
    Adlakha RC, Ashorn CL, Chan D, Zwelling LA.
    Cancer Res; 1989 Apr 15; 49(8):2052-8. PubMed ID: 2539251
    [Abstract] [Full Text] [Related]

  • 16. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
    D'Arpa P, Beardmore C, Liu LF.
    Cancer Res; 1990 Nov 01; 50(21):6919-24. PubMed ID: 1698546
    [Abstract] [Full Text] [Related]

  • 17. Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli.
    Huff AC, Leatherwood JK, Kreuzer KN.
    Proc Natl Acad Sci U S A; 1989 Feb 01; 86(4):1307-11. PubMed ID: 2537494
    [Abstract] [Full Text] [Related]

  • 18. Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA.
    Fernandes DJ, Danks MK, Beck WT.
    Biochemistry; 1990 May 01; 29(17):4235-41. PubMed ID: 2163274
    [Abstract] [Full Text] [Related]

  • 19. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA.
    Lin JH, Castora FJ.
    Arch Biochem Biophys; 1995 Dec 20; 324(2):293-9. PubMed ID: 8554321
    [Abstract] [Full Text] [Related]

  • 20. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
    Woynarowski JM, Sigmund RD, Beerman TA.
    Biochemistry; 1989 May 02; 28(9):3850-5. PubMed ID: 2473776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.